Gritstone bio Inc. (NASDAQ: GRTS)
$0.71
+0.0559 ( +8.50% ) 1.9M
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Market Data
Open
$0.71
Previous close
$0.66
Volume
1.9M
Market cap
$77.45M
Day range
$0.63 - $0.73
52 week range
$0.52 - $3.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 7 | Apr 29, 2024 |
8-k | 8K-related | 20 | Apr 02, 2024 |
8-k | 8K-related | 13 | Apr 01, 2024 |
8-k | 8K-related | 13 | Mar 05, 2024 |
10-k | Annual reports | 102 | Mar 05, 2024 |
8-k | 8K-related | 14 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 12, 2024 |
4 | Insider transactions | 1 | Feb 05, 2024 |
4 | Insider transactions | 1 | Feb 05, 2024 |